                                                                                                                                                                                      Enzi examines FDA drug approval speed  safety  March 1  2005 Washington  D C   U S  Senator Mike Enzi  R Wyo   Chairman of the Senate Health  Education  Labor and Pensions  HELP  Committee today said it is time to re evaluate the Food and Drug Administration s  FDA  organization and process for approving drugs  but cautioned we should not try to reinvent the wheel and develop a system that aims for an impossible standard of zero risk     We must not sacrifice safety to speed drugs to market  Enzi said  However  we must weigh benefits and risks on the same scale  As patients  every time we take a drug  we take a risk  so we should not overreact to recent events  Attempting to achieve a zero safety risk  would block millions from benefiting from life saving drugs and therapies     Convening the first of two hearings on the FDA Tuesday  Enzi focused today s hearing on examining how the agency makes decisions about new drugs and on reviewing the recent controversies regarding the approval process     Outlining his objectives for the FDA s role  Enzi maintained the public must be able to trust that the FDA will      ensure that companies are communicating the benefits and risks of their drugs to patients and physicians in a clear and consistent manner  and    keep tabs on the drugs on the market to ensure continued safety  and to take appropriate action if new information demonstrates new risks that were not apparent when a drug was initially approved     Enzi has scheduled a second hearing on Thursday  March 3 to examine steps the FDA is taking to address public concerns about the safety of prescription medications  The hearing also will evaluate the FDA s ability to handle the challenges it will face meeting its mission in the future                                                        March 2005 News Releases           Browse by                                                      Current record                                                                                                                                                                                                                                                                                                                                                                                       